National and Kapodistrian University of Athens
Συγκριτική μελέτη της δράσης αντιδιαβητικών φαρμάκων στην παθογένεια της οστεοπόρωσης
Abstract
dc:descriptionIntroduction: The effects of incretin-based drugs, like glucagon-like peptide-1 (GLP-1) receptor agonists and inhibitors of dipeptidyl peptidase-4 (DPP-4) on bone metabolism are not completely clear yet. The aim of this study is to elucidate how the different parameters of the incretin pathway affect bone quality in terms of biomechanical properties, bone turnover and mineral properties.Materials and methods: Forty 10-week-old Wistar rats were divided in four groups: a control group, a control diabetic group, a diabetic group treated with sitagliptin, and a diabetic group treated with exenatide. Type 2 Diabetes was simulated by dietary manipulation and low dose streptozotocin and then the two different incretin-based drugs were administered. The rats were sacrificed after five weeks of therapeutic treatment. Their serum was analyzed with ELISA method for basic bone turnover markers and their right femur was subjected to three-point bending test. Finally, hematoxylin/ eosin staining in addition to RAMAN spectroscopy were employed to access the collagen and mineral properties of the bone.Results: Both incretin- based drugs reduced osteoclast function, however, they were not able to restore osteoblastic function to normal. The net effect on bone strength was surprising: bone elasticity was restored by the antidiabetic treatment, but bone strength deteriorated. Exenatide had a more pronounced effect, confirming the suspicion that DPP4 may be a linking factor between reduced osteoclastic function and reduced bone formation.Conclusion: DPP4 receptors seems to be one of the links between reduced osteoclast function and reduced bone remodeling, so DPP4 inhibition can be more detrimental to the bone than GLP-1 receptor agonists.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Abdi, Arezoo
- Αμπντί, Αρεζού
Subjects
dc:subject × 18- Σακχαρώδης διαβήτης τύπου 2 (ΣΔτ2)
- Ινκρετίνες
- Οστεοπόρωση
- Εμβιομηχανική μελέτη
- Diabetes mellitus type II
- Incretins
- Biomechanics
- Osteoporosis
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Βασική ιατρική, άλλοι τομείς
- Κλινική Ιατρική
- Ορθοπεδική και Αθλιατρική
- Basic Medicine
- Medical and Health Sciences
- Basic medicine, miscellaneous
- Clinical Medicine
- Orthopedics and Sports Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/53764